Publications by authors named "Ramon Garcia-Ruiz"
Article Synopsis
- Hidradenitis suppurativa (HS) is a long-lasting inflammatory skin condition primarily affecting hair follicles, with limited treatment options available, mainly centered around the use of Adalimumab.
- Guselkumab, a monoclonal antibody that targets IL-23, has shown promise as a potential treatment for patients with HS who haven't responded well to existing therapies, even though it's primarily approved for psoriasis.
- A study involving patients from two university hospitals in Spain aimed to evaluate the effectiveness, dosage, and administration frequency of guselkumab in treating HS, in order to optimize treatment regimens and clarify its role in managing this condition.